🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
PepGen Inc.
Market Cap: Low
Employees: Low
PGN-EDO51
Pep Gen Inc. is a clinical-stage biotechnology company developing oligonucleotide therapeutics for neuromuscular and neurologic diseases. Its lead product, PGN-EDO51, is in Phase I trials for Duchenne muscular dystrophy.
Symbol: PEPG
Recent Price: $3.83
Industry: Biotechnology
CEO: Dr. James G. McArthur Ph.D.
Sector: Healthcare
Employees: 72
Address: 245 Main Street, Cambridge, MA 02142
Phone: 781-797-0979
Last updated: 2024-12-31